Paper Title
ALTERNATIVE TREATMENT OF PARKINSONS DISEASE: A REVIEW
Article Identifiers
Keywords
Parkinson's disease, neurodegenerative disorders, dopamine, levodopa, dopaminergic therapy, dementia, non-dopaminergic traits, medical history, combination therapies, etc.
Abstract
Parkinson’s disease typically develops between the ages of 55 and 65 years and occurs in 1 to 2% of persons over the age of 60 years. Approximately 0.3% of the general population is affected, and the prevalence is higher among men than women, with a ratio of 1.6 to 1.0. As the population ages, the incidence of PD is expected to increase dramatically in the coming decades. Current therapies are largely based on dopamine replacement strategies using the dopamine precursor levodopa. However, chronic treatment is accompanied by the development of motor complications and the disease progresses inexorably. Moreover, disease progression is associated with the emergence of symptoms such as freezing, falls, and dementia that cannot be adequately controlled with dopaminergic therapy. Indeed, these non-dopaminergic traits are now recognized to be common and a major cause of disability in patients with progressive disease. Many different treatments and therapeutic strategies have been evaluated, and many promising approaches are currently being tested in the laboratory and clinic. As a result, many new therapeutics and strategic approaches to treat different stages of Parkinson's disease have become available. Treatment for Parkinson's disease typically involves a combination of treatments. An important part of Parkinson's disease treatment is drug therapy supported by various combination therapies. Treatment is primarily aimed at relieving symptoms and side effects, as the disease itself cannot currently be cured. Each Parkinson's disease course is different, and the type and severity of symptoms vary widely. What is particularly worrying to one person may not be noticed by another. In addition to symptoms, medical history, age, and living environment also play an important role. Therefore, individualized treatment is necessary.
Downloads
How To Cite (APA)
Mohammed Mudassir, Aamir Khan Yusuf Khan, & Nazneen Begum (November-2022). ALTERNATIVE TREATMENT OF PARKINSONS DISEASE: A REVIEW. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(11), c18-c37. https://ijnrd.org/papers/IJNRD2211204.pdf
Issue
Volume 7 Issue 11, November-2022
Pages : c18-c37
Other Publication Details
Paper Reg. ID: IJNRD_184153
Published Paper Id: IJNRD2211204
Downloads: 000122253
Research Area: Pharmacy
Author Type: Indian Author
Country: Hyderabad, Telangana, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2211204.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2211204
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.
For more details, refer to the official notice: UGC Public Notice
Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: December 2025
Current Issue: Volume 10 | Issue 12 | December 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Dec-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
Approval, Licenses and Indexing: More Details
:
